|
Volumn 35, Issue 5-6, 1999, Pages 408-412
|
Changes in gene expression and targets for therapy
|
Author keywords
Gene expression; Marker; Prostate cancer; Therapy
|
Indexed keywords
CANCER VACCINE;
KALLIKREIN;
MELANOMA ANTIGEN;
MEMBRANE ANTIGEN;
PROSTATE SPECIFIC ANTIGEN;
TUMOR ANTIGEN;
TUMOR MARKER;
ANGIOGENESIS;
APOPTOSIS;
CANCER IMMUNOTHERAPY;
CELL ADHESION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG TARGETING;
GENE EXPRESSION;
GENE OVEREXPRESSION;
GENE TARGETING;
GENE THERAPY;
HUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS;
GENE EXPRESSION;
HUMANS;
MALE;
PROGNOSIS;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
TREATMENT OUTCOME;
|
EID: 0032943462
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000019917 Document Type: Conference Paper |
Times cited : (5)
|
References (28)
|